Interestingly, upon reviewing gene expression profiles obtained from progressive and non-progressive endometrial cancer, a number of inhibitors of Wnt/β-catenin signaling were indeed found to be down-regulated in progressive disease (DKK1, DKK4 and WIF1). The gene discussed is DKK1; the disease is endometrial cancer.